CLOV vs STOK
Clover Health Investments Corp (CLOV) versus Stoke Therapeutics Inc (STOK) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Stoke Therapeutics Inc (STOK) is a biotechnology company listed on NASDAQ.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported STOK revenue for 2024-12-31 was $36.6M. Net income was -$89.0M. Revenue was up 316.3% from 2023-12-31 to 2024-12-31. STOK currently screens at market cap $1.88B.
CLOV currently screens at market cap $1.55B. STOK currently screens at market cap $1.88B.
Not investment advice. Open the CLOV and STOK stock pages for the full models.
Not investment advice.